Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0420 per EA under NDC 65862000701. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 28, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862000701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077031FDA Approved
10/28/2004
TE Code
AB
On Market Since
10/28/2004
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0420 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0347 (Oct 23, 2019) |
| 52-week high | $0.0464 |
| 52-week low | $0.0420 |
| Median price | $0.0393 |
| Average price | $0.0399 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0420 per EA (NDC 65862000701), effective Aug 19, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has risen 5.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0393 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 65862000701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.